Open |
S2209 |
VRd-Lite versus DRd followedby Len+/-Dara |
5/30/2023 |
|
5% |
|
|
Open |
S2210 |
Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency |
8/14/2023 |
|
2% |
|
|
Open |
S2212 |
SCARLET |
7/21/2023 |
|
6% |
|
|
Open |
S2213 |
A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab… |
12/1/2023 |
|
0% |
|
|
Open |
S2302 |
PRAGMATICA - LUNG |
3/6/2023 |
|
69% |
|
|
Open |
S2303 |
Adding Nivolumab to Usual Treatment for People with Advanced Stomach or Esophageal Cancer |
5/6/2024 |
|
|
|
|
Open |
S9808 |
Admin. protocol |
6/15/1998 |
|
|
|
|
Open |
SLA01 |
IMMUNE CHECKPOINTS IN GASTRIC CANCER FROM LATIN AMERICAN COUNTRIES |
|
|
0% |
|
|
Closed |
S0000 |
SELECT (Selenium and Vitamin E Cancer Prevention Trial) |
7/25/2001 |
6/24/2004 |
100% |
|
Published
|
Closed |
S0000A |
PREADVISE |
5/17/2002 |
9/30/2009 |
72% |
|
Published
|
Closed |
S0000B |
SELECT Eye Endpoints (SEE) |
7/1/2004 |
7/31/2015 |
|
|
Published
|
Closed |
S0000C |
RAS |
6/4/2004 |
5/1/2007 |
94% |
|
Published
|
Closed |
S0000D |
Adenomatous Colorectal Polyps (ACP) |
6/3/2008 |
5/28/2013 |
100% |
|
Published
|
Closed |
S0001 |
Glioblastoma Multiforme/Gliosarcoma |
9/1/2001 |
11/15/2005 |
46% |
|
Published
|
Closed |
S0002 |
Smoking Cessation Stage I & II NSCLC |
1/1/2002 |
1/1/2004 |
2% |
|
|
Closed |
S0003 |
Carbo/Pac + Tirapazamine vs. Carbo/Pac in Adv. NSCLC; Selected IIIB & IV |
11/15/2000 |
11/15/2002 |
72% |
|
Published
|
Closed |
S0004 |
Tirapazamine/Cis/Etopo/RT in Limited SCLC |
10/15/2000 |
4/1/2002 |
60% |
|
Published
|
Closed |
S0007 |
Advanced, Recurrent, or Metastatic |
11/1/2000 |
5/15/2003 |
100% |
|
Published
|
Closed |
S0008 |
High Dose IFN vs. Cis/Vinblastine/DTIC + IL-2 & IFN in High Risk Melanoma |
8/1/2000 |
11/15/2007 |
90% |
|
Published
|
Closed |
S0009 |
OVARIAN |
3/15/2001 |
2/1/2006 |
100% |
|
Published
|